ICD-10 Coding for ESBL Urinary Tract Infection(B96.20, B96.20B, B96.20U)
Learn how to accurately code ESBL urinary tract infections using ICD-10, including primary, ancillary, and differential codes. Ensure compliance and optimize reimbursement.
Complete code families applicable to ESBL Urinary Tract Infection
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| N39.0 | Urinary tract infection, site not specified | Use when diagnosing a urinary tract infection without specifying the site. |
|
| Z16.12 | Resistance to extended spectrum beta-lactamase (ESBL) | Use as a secondary code to indicate ESBL resistance in infections. |
|
| B96.20 | Unspecified Escherichia coli [E. coli] as the cause of diseases classified elsewhere | Use when E. coli is identified as the causative organism in an infection. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutESBL Urinary Tract Infection
Alternative codes to consider when ruling out similar conditions
Use if the infection is confirmed to be in the bladder.
Documentation & Coding Risks
Avoid these common issues when documenting ESBL Urinary Tract Infection.
Vague documentation of resistance
Impact
Clinical: May lead to inappropriate antibiotic therapy., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials or reduced reimbursement.
Mitigation
Use specific terms like 'ESBL-producing' and document confirmatory tests., Educate clinicians on the importance of detailed documentation.
Using Z16.12 as a primary code
Impact
Reimbursement: Incorrect sequencing can lead to denied claims., Compliance: Non-compliance with ICD-10 coding guidelines., Data Quality: Inaccurate data representation of the patient's condition.
Mitigation
Always use Z16.12 as a secondary code following the primary infection code.
Omitting organism code when identified
Impact
Reimbursement: Potential underpayment due to incomplete coding., Compliance: Failure to fully document the infection's etiology., Data Quality: Loss of specificity in clinical data.
Mitigation
Include B96.20 when E. coli is identified as the causative organism.
Incomplete coding of resistance
Impact
Failure to code ESBL resistance can lead to audit findings.
Mitigation
Ensure all cases of antibiotic resistance are coded with Z16.12 when applicable.